MADELYN JABLONSKI: Open Payments
NPI 1700559424 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 62 payments from 17 companies in 2025. Trend: 2023 $419 · 2024 $949 · 2025 $1,693
Food & beverage: $1,559Education: $134
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $453 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $291 |
| Sumitomo Pharma America, Inc. | 8 | $174 |
| TOLMAR, INC. | 9 | $163 |
| Medtronic, Inc. | 2 | $159 |
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| UROGEN PHARMA, INC. | 3 | $72 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| BIOPROTECT MEDICAL, INC. | 1 | $48 |
| Hologic Sales and Service, LLC | 1 | $24 |
Products named: ERLEADA, Nubeqa, GEMTESA, INTERSTIM, LYNPARZA, JATENZO, ELIGARD, KEYTRUDA.
Industry payments across PA — which companies pay providers there.
